Details of the Drug

General Information of Drug (ID: DMXB7V8)

• Drug Name: Naxitamab

Indication

Disease Entry	ICD 11	Status	REF
Neuroblastoma	2D11.2	Approved	[1]
Osteosarcoma	2B51	Phase 2	[2]

• Affected Organisms: Humans
• ATC Code:
  L01FX21: Naxitamab
  L01FX: Other monoclonal antibodies and antibody drug conjugates
  L01F: MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
  L01: ANTINEOPLASTIC AGENTS
  L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
• Cross-matching ID:
  UNII: 9K8GNJ2874
  DrugBank ID: DB15965
  TTD ID: D0HI5D
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2020
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)